Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
252.00
Ask:
257.00
Spread: 5.00 (1.984%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

AGM and Interim Management Statement

5 Nov 2015 07:00

RNS Number : 6098E
Wilmington PLC
05 November 2015
Β 

5 November 2015

Β 

Wilmington plc

Β 

AGM and Interim Management Statement

Β 

Wilmington plc ("Wilmington" or "the business"), the knowledge leader in Risk & Compliance, Finance, Legal, and Insight announces its Interim Management Statement for the three month period to 30 September 2015 with comments reflecting trading to-date. This statement is also being made at the Group's Annual General Meeting being held today.

Β 

Trading Update

Wilmington has started the year positively with revenue up 8% during the three months ended 30 September 2014 accompanied by good profit growth. The business overall is performing well and in line with expectations, with good growth coming from the Finance division in particular. As previously reported, this growth was to some extent offset by continued declines in revenue from Legal and a mixed start from Insight. The Risk & Compliance division continues to grow despite a very strong comparator period, with encouraging growth from Axco and Compliance Week. Underlying revenue growth, adjusting for the acquisition of Financial Research Associates ("FRA" acquired 6 July 2015) and the disposal of the Media business was 1%, again reflecting the strong comparator period.

During the three month period, Wilmington continued to see growth in reported operating profits and operating margins.

Β 

Operational Review

Wilmington Risk & Compliance: This division provides in-depth regulatory and compliance accredited training and information, market intelligence, and analysis. It focuses on the international financial services and international insurance markets as well as the UK pensions industry.

Β 

Wilmington Risk & Compliance delivered revenue and contribution growth during the period, measured against a strong prior year comparator which had benefited from a number of large compliance based induction assignments. The compliance business continues to enjoy significant demand for its accredited face-to-face training in both public events and bespoke in-house assignments. To strengthen our infrastructure and support the expected continued growth in revenue from compliance, we have also invested in a number of senior appointments over the last four months. In addition the Risk business, which primarily services the information needs of insurance and pensions professionals, delivered solid growth in its revenue and profits with Axco and Compliance Week showing good first quarter contributions.

Β 

Β 

Wilmington Finance: This division provides corporate finance and capital markets training as well as training and support services for qualified accountants in the UK in the profession and industry.

Β 

Finance recorded strong revenue growth continuing the trends experienced in 2014/15. Given the operational gearing of the business, the revenue growth has delivered an increase in both margin and in profit. The Accountancy training and support business enjoyed a strong start, benefitting in particular from demand for technical and marketing support around the UK Government's additional July 2015 fiscal budget.

Β 

Wilmington Legal: The Legal division provides a range of training, professional support services and information including Continuing Legal Education (CLE), expert witness training, databases and magazines to legal professionals.

Β 

The Legal division overall experienced a weaker than expected first quarter reflecting continued reduced demand for face to face CLE training and conferences. The exception has been CLT Scotland, which has benefited from increased Scottish Legislation and paralegal training demand. Bond Solon, which provides law services and training for non-lawyers, also delivered encouraging revenue growth. The overall revenue decline from Law services for Lawyers in England and Wales was offset to a large extent by our flexible cost base and the strong first quarter performance from CLT Scotland and Bond Solon.

Β 

Wilmington Insight: The Insight division provides analysis and clarity to customer-focused organisations, enabling them to better understand and connect with their markets.

Β 

As previously reported, the division has had a mixed start. It has seen a marked reduction in lower margin healthcare marketing data and mailing service sales, offset to a degree by strong growth from Onmedica. This has been supported by the continued momentum from NHiS which is enjoying increased demand for analyst-led insightful information. The data suppression and charities businesses remained largely flat as expected. Overall profits were down slightly on the same period in 2014.

Β 

FRA: FRA will be reported under the Insight (for healthcare networking events) and under the Finance divisions (for finance networking events) going forward. FRA reported a good first three months' trading, enjoying particularly strong demand for its Healthcare events. FRA continues to generate an excellent pipeline of sponsorship sales, and there is strong early demand for its flagship healthcare event, RISE Nashville, to be held in March 2016. The integration of FRA is going well; we have already seen benefits of intra-group collaboration and expect to announce some exciting initiatives during 2016.

Β 

Β 

Cash Flow

Net debt as at 30 September 2015 was Β£36.3m (2014: Β£32.6m) reflecting the acquisition of FRA for Β£8.3m.

Β 

Outlook

The overall trading outlook has not changed since the full year 2015 results announcement. We continue to see the trends of tighter regulatory control and more complex legislation being implemented in most of our key markets, which in turn is driving demand for many of our products and services. We have also invested in our Compliance business which is providing the infrastructure and support for anticipated future growth. Overall, the financial performance is in line with the Board's expectations and Wilmington is on track to deliver against expectations for the full year.

Β 

-End-

Β 

Β 

Β 

For further information, please contact:

Β 

Β 

Wilmington plc

Pedro Ros, Chief Executive Officer

Tony Foye, Chief Financial Officer

Β 

FTI Consulting

Charles PalmerΒ / Emma Appleton

Β 

020 7422 6800

Β 

Β 

Β 

020 3727 1000

Β 

Β 

Notes to Editors

Β 

Wilmington plc is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Finance and Legal as well as the Insight leader in a number of chosen industries. Capitalised at approximately Β£230 million, Wilmington floated on the London Stock Exchange in 1995

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCBIBRTMBTMBFA
Date   Source Headline
19th Mar 20184:18 pmRNSBoard Change - Correction
19th Mar 201811:34 amRNSHolding(s) in Company
16th Mar 20181:06 pmRNSBoard Change
15th Mar 20183:36 pmRNSHolding(s) in Company
2nd Mar 20182:13 pmRNSDirector/PDMR Shareholding
1st Mar 20189:00 amRNSVoting Rights and Capital
26th Feb 20188:34 amRNSDirector/PDMR Shareholding
22nd Feb 20183:49 pmRNSHolding(s) in Company
22nd Feb 20187:00 amRNSInterim Results
22nd Feb 20187:00 amRNSAppointment of Martin Morgan as Chairman
14th Feb 20182:50 pmRNSHolding(s) in Company
1st Feb 20189:10 amRNSHolding(s) in Company
1st Feb 20189:00 amRNSVoting Rights and Capital
4th Jan 20187:00 amRNSAcquisition of Interactive Medica
2nd Jan 20189:00 amRNSVoting Rights and Capital
18th Dec 20174:43 pmRNSNotification of Interim Results
1st Dec 20177:00 amRNSVoting Rights and Capital
29th Nov 20177:00 amRNSAppointment of new Chief Financial Officer
23rd Nov 201710:34 amRNSDirector/PDMR Shareholding
2nd Nov 20172:43 pmRNSResult of AGM
2nd Nov 20177:00 amRNSAGM and Q1 Trading Update
1st Nov 20179:12 amRNSVoting Rights and Capital
6th Oct 20175:58 pmRNSHolding(s) in Company
5th Oct 20173:45 pmRNSHolding(s) in Company
5th Oct 20173:44 pmRNSHolding(s) in Company
2nd Oct 20172:49 pmRNSVoting Rights and Capital
29th Sep 20179:27 amRNSDirector/PDMR Shareholding
27th Sep 20177:00 amRNSProposed Board Change
21st Sep 20171:47 pmRNSDirector/PDMR Shareholding
20th Sep 201711:50 amRNSShare Awards
18th Sep 20172:01 pmRNSVoting Rights and Capital
14th Sep 20172:48 pmRNSDirector/PDMR Shareholding
14th Sep 20179:33 amRNSDirector/PDMR Shareholding
13th Sep 20174:03 pmRNSDirector/PDMR Shareholding
13th Sep 20177:01 amRNSBoard Change
13th Sep 20177:00 amRNSFinal Results
22nd Aug 20171:52 pmRNSNotification of Final Results
18th Aug 20171:11 pmRNSHolding(s) in Company
1st Aug 201712:21 pmRNSVoting Rights and Capital
3rd Jul 20177:00 amRNSVoting Rights and Capital
28th Jun 20179:44 amRNSDirector/PDMR Shareholding
21st Jun 20173:05 pmRNSHolding(s) in Company
16th Jun 20174:35 pmRNSPrice Monitoring Extension
1st Jun 201712:00 pmRNSVoting Rights and Capital
19th May 201711:56 amRNSHolding(s) in Company
18th May 20177:00 amRNSTrading Statement
4th May 20177:00 amRNSProperty Disposal
3rd May 20171:56 pmRNSHolding(s) in Company
2nd May 20172:21 pmRNSVoting Rights and Capital
3rd Apr 201711:33 amRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.